“redmile-group” Archives

in
Entry Author Date Location
One Year Post-Launch, Yumanity Lands $45M For Yeasty Discovery 02/10/16 Boston
Eyeing First Trials, Syros Brings in $40M and More Crossovers 01/13/16 Boston
Syros Pharmaceuticals Garners $40,000,000 New Financing 01/13/16 Boston
Xeris Pharmaceuticals Secures $41,000,000 Series C Funding Round 01/12/16 Texas
Cancer Vaccines Back in Vogue as VCs Put $102M Into Gritstone Oncology 10/20/15 San Francisco
Audentes Therapeutics Garners $65,000,000 Series C Funding 10/14/15 San Francisco
Genalyte Secures $44,000,000 Series C Financing 08/19/15 San Diego
WaVe Joins the Crossover Party With $66M Series B for RNA Drugs 08/18/15 Boston
WAVE Life Sciences Garners $66,000,000 Series B Funding 08/18/15 Boston
Ex-Teva CEO’s Brain Disease Startup, Ovid, Bags $75M From Crossovers 08/11/15 New York
Diagnostic-Maker Scanadu Lands $35M As FDA Submission Nears 04/27/15 San Francisco
East Coast Biotech Roundup: Forum, Crossovers, Immuno-Oncology & More 04/24/15 Boston
Crossovers Arm Jounce With $56M For “Next Step” Immuno-Oncology 04/23/15 Boston
Raleigh-Durham Roundup: BioCryst, Scioderm, Red Hat & More 12/22/14 Raleigh Durham
East Coast Biotech Roundup: Regeneron, Sage, Tara, Alnylam, & More 11/14/14 Boston
East Coast Biotech Roundup: Sarepta, Aegerion, Syros, Aileron & More 10/31/14 Boston
Syros Raises $53M More To Push Gene-Control Drugs Into Human Trials 10/27/14 Boston
First Aid Shot Therapy Obtains Series B Financing Round 02/10/14 San Francisco
Invitae Secures $40,000,000 Series E Financing Round 12/12/13 San Francisco
Amicus Wheels, Deals, Restructures Following Fabry Drug Setback 11/20/13 New York
Trivascular Obtains $40,000,000 Series E Funding Round 11/18/13 San Francisco
Scanadu Obtains $10,500,000 Series A Financing 11/13/13 San Francisco
Foundation Medicine Secures $42,500,000 Series B Financing 09/21/12 Boston
Foundation Medicine Grabs $42.5M For Cancer Genome Test 09/20/12 Boston
Trivascular Lands $60,000,000 Series D Funding Round 06/05/12 San Francisco
Castlight Health Receives $100,000,000 Series D Funding Round 05/01/12 San Francisco
SD Life Sciences Roundup: Optimer, Illumina, & Deals, Deals, Deals 04/12/12 San Diego
Polaris Prepares for Liver Cancer Trial, Goal Draws Near for Hepatitis C Drug, & More San Diego Life Sciences News 04/28/11 San Diego
Illumina Joins $41M Bet on Oxford Nanopore 04/26/11 San Diego
Page 1 of 1